In Vitro Assays for T Cell Engagers - From Bench to Data Driven Decisions

Explore strategic bioassay design and optimization for T cell engagers in oncology through this comprehensive webinar that addresses the limitations of standard bioassays when evaluating these complex therapeutic agents. Learn how to develop context-specific in vitro models that generate meaningful preclinical data by examining diverse mechanisms of action and functional complexity inherent in T cell engager therapeutics. Discover proven strategies for rational assay design including T cell activation, redirected killing, cytokine release, and target-specific inhibition assays that support robust assessment of drug potency, specificity, and mechanisms of action. Gain insights into how in vitro models such as bispecific format evaluation can effectively bridge the gap between discovery research and translational relevance in drug development. Master practical approaches for transforming complex bioassay data into actionable insights that guide critical decision-making throughout the drug development process, with real-world case studies demonstrating successful implementation of tailored bioassays for T cell engagers in preclinical oncology research.